AURINIA PHARMACEUTICALS INC
(05156V102)
ファンドの報告 AURINIA PHARMACEUTICALS INC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Consonance Capital Management LP | 4,222,558 | $27,784k | Jun 30, 2019 | Aug 14, 2019 | |
| Orbimed Advisors LLC | 3,531,002 | $23,234k | Jun 30, 2019 | Aug 14, 2019 | |
| Polar Capital LLP | 3,312,723 | $21,798k | Jun 30, 2019 | Aug 14, 2019 | |
| VIVO Capital LLC | 1,913,623 | $12,592k | Jun 30, 2019 | Aug 13, 2019 | |
| Acuta Capital Partners LLC | 935,000 | $6,152k | Jun 30, 2019 | Aug 14, 2019 | |
| Ironwood Investment Management LLC | 163,460 | $1,076k | Jun 30, 2019 | Aug 14, 2019 | |
| Renaissance Technologies LLC | 68,623 | $452k | Jun 30, 2019 | Aug 12, 2019 | |
| Nicholas Investment Partners LP | 39,845 | $262k | Jun 30, 2019 | Aug 9, 2019 | |
| Point72 Asset Management LP | 22,083 | $145k | Jun 30, 2019 | Aug 14, 2019 | |
| Gables Capital Management Inc | 850 | $6k | Jun 30, 2019 | Jul 31, 2019 |